NOVARTIS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.06 CHF | +1.67% |
|
+1.43% | +10.04% |
| 02:00pm | Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes | RE |
| May. 31 | NOVARTIS AG : UBS reiterates its Buy rating | ZD |
Chart: Technical Analysis
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- NOVN Stock
- NOVNEE Stock
- Charts Novartis AG
